Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Docosahexenoic Acid (22:6n-3, DHA) Supplementation on Risk Factors for Cardiovascular Disease in Hyperlipidemic Men

NCT00728338 is registered in ClinicalTrials.gov with USDA, Western Human Nutrition Research Center as lead sponsor.

NCT NCT00728338
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00728338 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Docosahexenoic Acid (22:6n-3, DHA) Supplementation on Risk Factors for Cardiovascular Disease in Hyperlipidemic Men
Lead sponsor
USDA, Western Human Nutrition Research Center
Phase
Not applicable
Overall status
Completed
Start date
June 30, 2003
Completion date
November 30, 2005
Enrollment
40 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hypertriglyceridemia